We analyzed the expression profile of putative surface (CD34, CD44, CD133) and nuclear markers (BMI1, OCT4) of stem cells in 10 lung cancer cell lines using flow cytometry (Table 1). This evidence concerns the gene CD44 and lung carcinoma.